EAM Investors, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$4,169,000
+226.0%
219,415
+181.3%
0.69%
+203.1%
Q4 2017$1,279,000
-60.0%
77,999
-63.4%
0.23%
-46.1%
Q3 2017$3,195,000
+225.7%
213,027
+91.1%
0.42%
+162.3%
Q2 2017$981,000
+14.1%
111,486
+18.4%
0.16%
+44.6%
Q4 2015$860,000
-8.0%
94,183
+53.8%
0.11%
-36.7%
Q2 2014$935,000
-34.5%
61,248
-22.4%
0.18%
-31.1%
Q1 2014$1,427,000
+2.8%
78,938
-21.0%
0.26%
+3.6%
Q4 2013$1,388,00099,8930.25%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders